The repertoire of mutational signatures in tobacco- and non-tobacco-induced oral cancer

Clin Transl Oncol. 2023 Dec;25(12):3332-3344. doi: 10.1007/s12094-023-03192-8. Epub 2023 Apr 14.

Abstract

The use of tobacco products is one of the established contributors toward the development and spread of oral cancer. Additionally, recent research has indicated oral microbiome, infections with Human papilloma virus (HPV), Epstein-Barr virus (EBV), Candida as significant contributing factors to this disease along with lifestyle habits. Deregulation of cellular pathways envisaging metabolism, transcription, translation, and epigenetics caused by these risk factors either individually or in unison is manifold, resulting in the increased risk of oral cancer. Globally, this cancer continues to exist as one of the major causes of cancer-related mortalities; the numbers in the developing South Asian countries clearly indicate yearly escalation. This review encompasses the variety of genetic modifications, including adduct formation, mutation (duplication, deletion, and translocation), and epigenetic changes evident in oral squamous cell carcinoma (OSCC). In addition, it highlights the interference caused by tobacco products in Wnt signaling, PI3K/Akt/mTOR, JAK-STAT, and other important pathways. The information provided also ensures a comprehensive and critical revisit to non-tobacco-induced OSCC. Extensive literature survey and analysis has been conducted to generate the chromosome maps specifically highlighting OSCC-related mutations with the potential to act as spectacles for the early diagnosis and targeted treatment of this disease cancer.

Keywords: DNA adducts; Mutations; Tobacco; Viral infections.

Publication types

  • Review

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / genetics
  • Head and Neck Neoplasms* / complications
  • Herpesvirus 4, Human / genetics
  • Humans
  • Mouth Neoplasms* / genetics
  • Mouth Neoplasms* / pathology
  • Mutation
  • Phosphatidylinositol 3-Kinases / genetics
  • Squamous Cell Carcinoma of Head and Neck

Substances

  • Phosphatidylinositol 3-Kinases